The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
Abstract
Objective: Severe inflammation and astrocyte loss with profound demyelination in spinal cord and optic nerves are typical pathological features of neuromyelitis optica (NMO). A diagnostic hallmark of this disease is the presence of serum autoantibodies against the water channel aquaporin‐4 (AQP‐4) on astrocytes. Methods: We induced acute T‐cell–mediated experimental autoimmune encephalomyelitis in Lewis rats and confronted the animals with an additional application of immunoglobulins from AQP‐4 antibody–positive and –negative NMO patients, multiple sclerosis patients, and control subjects. Results: The immunoglobulins from AQP‐4 antibody–positive NMO patients are pathogenic. When they reach serum titers in experimental animals comparable with those seen in NMO patients, they augment clinical disease and induce lesions in the central nervous system that are similar in structure and distribution to those seen in NMO patients, consisting of AQP‐4 and astrocyte loss, granulocytic infiltrates, T cells and activated macrophages/microglia cells, and an extensive immunoglobulin and complement deposition on astrocyte processes of the perivascular and superficial glia limitans. AQP‐4 antibody containing NMO immunoglobulin injected into naïve rats, young rats with leaky blood–brain barrier, or after transfer of a nonencephalitogenic T‐cell line did not induce disease or neuropathological alterations in the central nervous system. Absorption of NMO immunoglobulins with AQP‐4–transfected cells, but not with mock‐transfected control cells, reduced the AQP‐4 antibody titers and was associated with a reduction of astrocyte pathology after transfer. Interpretation: Human anti–AQP‐4 antibodies are not only important in the diagnosis of NMO but also augment disease and induce NMO‐like lesions in animals with T‐cell–mediated brain inflammation. Ann Neurol 2009;66:630–643
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,566
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Self-citationRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288 · cited 1×
“These autoantibodies can be detected in more than 75% of all patients(4) and are directed against aquaporin-4 (AQP-4), a water channel expressed on astrocytes.(5,6) Using these antibodies as a diagnostic marker allowed researchers to define the clinical spectrum of the disease, which in essential aspects differs from…”
BackgroundThe spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
Bush, T. G., Puvanachandra, N., Horner, C. H., Polito, A., Ostenfeld, T., Svendsen, C. N., Mucke, L., Johnson, M. H., & Sofroniew, M. V. (1999) · Neuron · doi:10.1016/s0896-6273(00)80781-3 · Cited by 1,116
Ben‐Nun, A., Wekerle, H., & Cohen, I. R. (1981) · European Journal of Immunology · doi:10.1002/eji.1830110307 · Cited by 916
Paraneoplastic syndromes of the CNS
Dalmau, J., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 873
Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716
Self-citationLinington, C., Bradl, M., Lassmann, H., Brunner, C., & Vass, K. (1988) · PubMed · Cited by 708
Self-citationGold, R., Schmied, M. C., Giegerich, G., Breitschopf, H., Hartung, H., Toyka, K. V., & Lassmann, H. (1994) · PubMed · Cited by 675
Self-citationBrain Abnormalities in Neuromyelitis Optica
Pittock, S. J., Lennon, V. A., Krecke, K., Wingerchuk, D. M., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.390 · Cited by 675
An open label study of the effects of rituximab in neuromyelitis optica
Cree, B. A. C., Lamb, S., Morgan, K., Chen, A., Waubant, E., & Genain, C. (2005) · Neurology · doi:10.1212/01.wnl.0000159399.81861.d5 · Cited by 646
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Self-citationLoss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., & Itoyama, Y. (2007) · Brain · doi:10.1093/brain/awm047 · Cited by 614
Self-citationIntrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica
Bennett, J. L., Lam, C., Kalluri, S. R., Saikali, P., Bautista, K., Dupree, C., Glogowska, M., Case, D., Antel, J. P., Owens, G. P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21802 · Cited by 590
Storch, M. K., Stefferl, A., Brehm, U., Weissert, R., Wallström, E., Kerschensteiner, M., Olsson, T., Linington, C., & Lassmann, H. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00194.x · Cited by 522
Self-citationPathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
Hinson, S. R., Pittock, S. J., Lucchinetti, C. F., Roemer, S. F., Fryer, J. P., Kryzer, T. J., & Lennon, V. A. (2007) · Neurology · doi:10.1212/01.wnl.0000289761.64862.ce · Cited by 494
Myasthenia Gravis: Passive Transfer from Man to Mouse
Toyka, K. V., Brachman, D. B., Pestronk, A., & Kao, I. (1975) · Science · doi:10.1126/science.1179220 · Cited by 441
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
Jarius, S., Aboul-Enein, F., Waters, P., Kuenz, B., Hauser, A., Berger, T., Lang, W., Reindl, M., Vincent, A., & Kristoferitsch, W. (2008) · Brain · doi:10.1093/brain/awn240 · Cited by 435
Self-citationNMO-IgG predicts the outcome of recurrent optic neuritis
Matiello, M., Lennon, V. A., Jacob, A., Pittock, S. J., Lucchinetti, C. F., Wingerchuk, D. M., & Weinshenker, B. G. (2008) · Neurology · doi:10.1212/01.wnl.0000303817.82134.da · Cited by 367
Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica
Jarius, S., Paul, F., Franciotta, D., Waters, P., Zipp, F., Hohlfeld, R., Vincent, A., & Wildemann, B. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0764 · Cited by 335
A secondary progressive clinical course is uncommon in neuromyelitis optica
Wingerchuk, D. M., Pittock, S. J., Lucchinetti, C. F., Lennon, V. A., & Weinshenker, B. G. (2007) · Neurology · doi:10.1212/01.wnl.0000254502.87233.9a · Cited by 326
Current protocols in immunology
Borek, F. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90295-5 · Cited by 322
Fukunaga, H., Engel, A. G., Lang, B., Newsom-Davis, J., & Vincent, A. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.24.7636 · Cited by 294
Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis
Waters, P., Jarius, S., Littleton, E., Leite, M. I., Jacob, S., Gray, B., Geraldes, R., Vale, T., Jacob, A., Palace, J., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.913 · Cited by 294
Piddlesden, S. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90424-6 · Cited by 287
Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica
Watanabe, S., Nakashima, I., Misu, T., Miyazawa, I., Shiga, Y., Füjihara, K., & Itoyama, Y. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071174 · Cited by 284
Self-citationAdelmann, M., Wood, J., Benzel, I., Fiori, P., Lassmann, H., Matthieu, J.-M., Gardinier, M. V., Dornmair, K., & Linington, C. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00124-7 · Cited by 232
Self-citationSommer, C., Weishaupt, A., Brinkhoff, J., Biko, L., Wessig, C., Gold, R., & Toyka, K. V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66376-3 · Cited by 224
Axonal Pathology in Multiple Sclerosis. A Historical Note
Kornek, B., & Lassmann, H. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00547.x · Cited by 197
Self-citationBerger, T., Weerth, S., Kojima, K., Linington, C., Wekerle, H., & Lassmann, H. (1997) · PubMed · Cited by 185
Self-citationAnti‐MuSK patient antibodies disrupt the mouse neuromuscular junction
Cole, R. N., Reddel, S. W., Gervásio, O. L., & Phillips, W. D. (2008) · Annals of Neurology · doi:10.1002/ana.21371 · Cited by 174
Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis
Bernal, F., Graus, F., Pifarré, À., Saiz, A., Benyahia, B., & Ribalta, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0498-0 · Cited by 171
Neuromyelitis optica pathogenesis and aquaporin 4
Graber, D. J., Levy, M., Kerr, D., & Wade, W. F. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-22 · Cited by 170
Misu, T., Takano, R., Fujihara, K., Takahashi, T., Sato, S., & Itoyama, Y. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.150698 · Cited by 165
Self-citationEstablishment of a New Sensitive Assay for Anti-Human Aquaporin-4 Antibody in Neuromyelitis Optica
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Ishii, N., & Itoyama, Y. (2006) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.210.307 · Cited by 165
Self-citationDysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis
Hochmeister, S., Grundtner, R., Bauer, J., Engelhardt, B., Lyck, R., Gordon, G., Korosec, T., Kutzelnigg, A., Berger, J. J., Bradl, M., et al. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235119.52311.16 · Cited by 160
Self-citationTakahashi, T., Miyazawa, I., Misu, T., Takano, R., Nakashima, I., Fujihara, K., Tobita, M., & Itoyama, Y. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.145391 · Cited by 158
Self-citationA case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
Nishiyama, S., Ito, T., Misu, T., Takahashi, T., Kikuchi, A., Suzuki, N., Jin, K., Aoki, M., Fujihara, K., & Itoyama, Y. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a82621 · Cited by 150
Self-citationDavenport, H. (1947) · Journal of the London Mathematical Society · doi:10.1112/jlms/s1-22.2.100 · Cited by 140
Piddlesden, S. J., Lassmann, H., Zimprich, F., Morgan, B. P., & Linington, C. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)91046-f · Cited by 137
Self-citationAutoimmune Disorders of Neuronal Potassium Channels
Newsom–Davis, J., Buckley, C. J., Clover, L. M., Hart, I. K., Maddison, P., TÜZÜM, E., & Vincent, A. C. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1254.022 · Cited by 130
Activation of humoral immunity and eosinophils in neuromyelitis optica
Correale, J. D., & Fiol, M. P. (2004) · Neurology · doi:10.1212/01.wnl.0000148481.80152.bf · Cited by 129
Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum
Kinoshita, M., Nakatsuji, Y., Moriya, M., Okuno, T., Kumanogoh, A., Nakano, M., Takahashi, T., Fujihara, K., Tanaka, K., & Sakoda, S. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32832776f4 · Cited by 113
Self-citationEnhanced expression of aquaporin 4 in human brain with inflammatory diseases
Aoki-Yoshino, K., Uchihara, T., Duyckaerts, C. J., Nakamura, A., Hauw, J., & Wakayama, Y. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1052-2 · Cited by 90
Sinclair, C., Kirk, J., Herron, B. M., FitzGerald, U., & McQuaid, S. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0169-2 · Cited by 88
Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis
Tanaka, M., Matsushita, T., Tateishi, T., Ochi, H., Kawano, Y., Mei, F.-J., Minohara, M., Murai, H., & Kira, J.-I. (2008) · Neurology · doi:10.1212/01.wnl.0000326589.57128.c3 · Cited by 88
Aboul‐Enein, F., Weiser, P., Höftberger, R., Lassmann, H., & Bradl, M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0047-y · Cited by 87
Self-citationInterferon‐γ potentiates antibody‐mediated demyelination in vivo
Vass, K., Heininger, K., Schäfer, B., Linington, C., & Lassmann, H. (1992) · Annals of Neurology · doi:10.1002/ana.410320212 · Cited by 69
Self-citationNicchia, G. P., Cogotzi, L., Rossi, A., Basco, D., Brancaccio, A., Svelto, M., & Frigeri, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05302.x · Cited by 68
Alexander, J. J., Bao, L., Jacob, A., Kraus, D. M., Holers, V. M., & Quigg, R. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.09.005 · Cited by 68
Weinstock‐Guttman, B., Miller, C., Yeh, E. A., Stosic, M., Umhauer, M., Batra, N. N. A., Munschauer, F., Zivadinov, R., & Ramanathan, M. K. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508092811 · Cited by 42
Lang, B., Molenaar, P. C., Newsom–Davis, J., & Vincent, A. C. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb02733.x · Cited by 35
Takano, R., Misu, T., Takahashi, T., Izumiyama, M., Fujihara, K., & Itoyama, Y. (2008) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.215.55 · Cited by 27
Self-citationWarabi, Y., Yagi, K., Hayashi, H., & Matsumoto, Y. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.06.011 · Cited by 26
[Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu, T., Fujihara, K., & Itoyama, Y. (2008) · PubMed · Cited by 25
Self-citationAboul‐Enein, F., Bauer, J., Klein, M., Schubart, A., Flügel, A., Ritter, T., Kawakami, N., Siedler, F., Linington, C., Wekerle, H., et al. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.12.1284 · Cited by 25
Self-citationAnti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance?
Bradl, M., & Lassmann, H. (2008) · PubMed · Cited by 23
Self-citation
Cited by
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
Jarius, S., Ruprecht, K., Wildemann, B., Kuempfel, T., Ringelstein, M., Geis, C., Kleiter, I., Kleinschnitz, C., Berthele, A., Brettschneider, J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-14 · Cited by 764
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Aquaporin 4 and neuromyelitis optica
Papadopoulos, M. C., & Verkman, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 597
Neuromyelitis Optica Study Group (NEMOS), Trebst, C., Jarius, S., Berthele, A., Paul, F., Schippling, S., Wildemann, B., Borisow, N., Kleiter, I., Aktas, O., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7169-7 · Cited by 595
Metadata
- Authors
- Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M., Bauer, J., Berger, T., Fujihara, K., Itoyama, Y., & Lassmann, H.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2009-11
- Volume
- 66
- Issue
- 5
- Pages
- 630-643
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2149429081
- Cited by
- 563
- References
- 60
- FWCI
- 40.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.